Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib.
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UKIssue Date
2016-08-19
Metadata
Show full item recordAbstract
Identification of patients with advanced HCC-deriving preferential benefit from sorafenib is desirable, and treatment-related adverse events are potential clinical biomarkers.Citation
Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib. 2016: Clin Transl OncolJournal
Clinical & Translational OncologyDOI
10.1007/s12094-016-1537-6PubMed ID
27541594Type
ArticleLanguage
enISSN
1699-3055ae974a485f413a2113503eed53cd6c53
10.1007/s12094-016-1537-6
Scopus Count
Collections
Related articles
- Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma.
- Authors: Yada M, Masumoto A, Motomura K, Tajiri H, Morita Y, Suzuki H, Senju T, Koyanagi T
- Issue date: 2014 Sep 21
- Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors.
- Authors: Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka O
- Issue date: 2015 Jun
- Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study.
- Authors: Lee S, Kim BK, Kim SU, Park SY, Kim JK, Lee HW, Park JY, Kim DY, Ahn SH, Tak WY, Kweon YO, Lee JI, Lee KS, Kim HJ, Han KH
- Issue date: 2014
- Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.
- Authors: Estfan B, Byrne M, Kim R
- Issue date: 2013 Aug
- Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience.
- Authors: Imedio ER, Beveridge RD, Urtasun JA, Campos GB, Estellés DL, Esparcia MF, Daroqui JC, Huerta ÁS, Ortiz AG, Salcedo JM
- Issue date: 2014 May